GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,979,708,000 | +185899.3% | 68,452 | +86.1% | 0.32% | +120.8% |
| Q1 2022 | $1,602,000 | +538.2% | 36,783 | +483.1% | 0.14% | +657.9% |
| Q2 2021 | $251,000 | +7.3% | 6,308 | -3.8% | 0.02% | +5.6% |
| Q1 2021 | $234,000 | -72.2% | 6,557 | -71.3% | 0.02% | -80.4% |
| Q4 2020 | $841,000 | -2.2% | 22,846 | +0.0% | 0.09% | -2.1% |
| Q3 2020 | $860,000 | -17.0% | 22,844 | -10.1% | 0.09% | -16.8% |
| Q2 2020 | $1,036,000 | +10.0% | 25,403 | +18.5% | 0.11% | +36.1% |
| Q1 2020 | $942,000 | -11.4% | 21,438 | -5.2% | 0.08% | -11.7% |
| Q4 2019 | $1,063,000 | -1.0% | 22,613 | -10.1% | 0.09% | +1.1% |
| Q3 2019 | $1,074,000 | +0.9% | 25,157 | -5.4% | 0.09% | +4.5% |
| Q2 2019 | $1,064,000 | -11.0% | 26,585 | -7.0% | 0.09% | -7.3% |
| Q1 2019 | $1,195,000 | -16.0% | 28,600 | -23.2% | 0.10% | -13.5% |
| Q4 2018 | $1,423,000 | -15.5% | 37,235 | -10.8% | 0.11% | +4.7% |
| Q3 2018 | $1,684,000 | -1.5% | 41,753 | -1.6% | 0.11% | +2.9% |
| Q2 2018 | $1,710,000 | +28.1% | 42,413 | +24.2% | 0.10% | +51.5% |
| Q1 2018 | $1,335,000 | +30.9% | 34,161 | +18.7% | 0.07% | +30.8% |
| Q4 2017 | $1,020,000 | -10.2% | 28,770 | +2.9% | 0.05% | -16.1% |
| Q3 2017 | $1,136,000 | -8.2% | 27,970 | -2.6% | 0.06% | -11.4% |
| Q2 2017 | $1,238,000 | +21.0% | 28,716 | +18.4% | 0.07% | +16.7% |
| Q1 2017 | $1,023,000 | +39.4% | 24,255 | +27.3% | 0.06% | +30.4% |
| Q4 2016 | $734,000 | -11.0% | 19,051 | -0.4% | 0.05% | -13.2% |
| Q3 2016 | $825,000 | +53.9% | 19,122 | +54.6% | 0.05% | +43.2% |
| Q2 2016 | $536,000 | -11.8% | 12,367 | -17.5% | 0.04% | -15.9% |
| Q1 2016 | $608,000 | +9.4% | 14,996 | +8.8% | 0.04% | +4.8% |
| Q4 2015 | $556,000 | +64.5% | 13,779 | -44.2% | 0.04% | +23.5% |
| Q3 2015 | $338,000 | -19.9% | 24,673 | +143.3% | 0.03% | -20.9% |
| Q2 2015 | $422,000 | +21.3% | 10,143 | +34.3% | 0.04% | +13.2% |
| Q1 2015 | $348,000 | +69.8% | 7,551 | +96.8% | 0.04% | -25.5% |
| Q4 2013 | $205,000 | – | 3,837 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |